Welcome to PsychU!

Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

This is a Virtual Event for PsychU members in Illinois, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota and Wisconsin.

In this presentation, the objectives are to:

  • Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
  • Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
  • Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder

Featuring

Heather-Fields

Heather Fields, PharmD, MPH, BCACP (OPDC)

Medical Science Liaison

Pam-Wolf

Pam Wolf, PharmD (OPDC)

Senior Medical Science Liaison

Heather Fields, PharmD, MPH, BCACP and Pam Wolf, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders